Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ADAMIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adamis Pharmaceuticals Corporation - ADMP By: Kahn Swick & Foti, LLC via Business Wire March 03, 2023 at 19:21 PM EST Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Adamis Pharmaceuticals Corporation (the “Company”) (NasdaqCM: ADMP) with DMK Pharmaceuticals, Corp. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-admp/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230303005410/en/Contacts Lewis S. Kahn KSF Managing Partner lewis.kahn@ksfcounsel.com 855-768-1857 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
ADAMIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adamis Pharmaceuticals Corporation - ADMP By: Kahn Swick & Foti, LLC via Business Wire March 03, 2023 at 19:21 PM EST Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Adamis Pharmaceuticals Corporation (the “Company”) (NasdaqCM: ADMP) with DMK Pharmaceuticals, Corp. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-admp/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230303005410/en/Contacts Lewis S. Kahn KSF Managing Partner lewis.kahn@ksfcounsel.com 855-768-1857
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Adamis Pharmaceuticals Corporation (the “Company”) (NasdaqCM: ADMP) with DMK Pharmaceuticals, Corp. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger undervalues the Company. If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-admp/ to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230303005410/en/
